Colon Cancer Clinical Trials
5 recruiting
Showing 1–20 of 32 trials
Recruiting
Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Pancreatic CancerLung CancerColon Cancer+3 more
RasCal Therapeutics, Inc.134 enrolled3 locationsNCT04678648
Recruiting
Genomic Services Research Program
Breast CancerColon Cancer
National Human Genome Research Institute (NHGRI)5,000 enrolled1 locationNCT02595957
Recruiting
Collection of Blood From Patients With Cancer
Breast CancerLiver CancerProstate Cancer+2 more
National Cancer Institute (NCI)1,750 enrolled1 locationNCT00034216
Recruiting
Phase 2
Phase II Trial of Lung Chemoemobolization
SarcomaColon CancerLung Non-Small Cell Carcinoma+4 more
City of Hope Medical Center30 enrolled2 locationsNCT05672108
Recruiting
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Breast CancerLiver CancerProstate Cancer+2 more
National Cancer Institute (NCI)750 enrolled1 locationNCT00451022
Recruiting
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Breast CancerEsophageal CancerProstate Cancer+10 more
Washington University School of Medicine100 enrolled1 locationNCT04354064
Recruiting
Not Applicable
Improving Care for Rural Patients With Solid Tumors
Breast CancerCervical CancerLung Cancer+5 more
University of Colorado, Denver320 enrolled14 locationsNCT04916990
Recruiting
Phase 1
A Study of PHN-012 in Patients With Advanced Solid Tumors
Pancreatic CancerColon CancerAdvanced Cancer+2 more
Pheon Therapeutics165 enrolled7 locationsNCT07127874
Recruiting
Integrated Cancer Repository for Cancer Research
Breast CancerLiver CancerEsophageal Cancer+47 more
University of Nebraska999,999 enrolled45 locationsNCT02012699
Recruiting
EXoPERT EMERALD Clinical Study
Breast CancerPancreatic CancerOvarian Cancer+2 more
EXoPERT1,400 enrolled9 locationsNCT07186296
Recruiting
Phase 1
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Breast CancerCervical CancerColon Cancer+4 more
Orano Med LLC48 enrolled4 locationsNCT05283330
Recruiting
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Breast CancerOvarian CancerLung Cancer+15 more
University Health Network, Toronto2,500 enrolled1 locationNCT03702309
Recruiting
Not Applicable
Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada
Lung CancersCancerColon Cancer+2 more
University of Calgary740 enrolled5 locationsNCT06960291
Recruiting
Phase 1
CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
Esophageal CancerGastric CancerLung Cancer+3 more
Chongqing Precision Biotech Co., Ltd108 enrolled1 locationNCT07179692
Recruiting
Not Applicable
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
Colon CancerLung Cancer (Diagnosis)Lung Adenocarcinoma+8 more
Barbara Nemesure100 enrolled1 locationNCT07161713
Recruiting
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Breast CancerLiver CancerGastric Cancer+9 more
Washington University School of Medicine10 enrolled1 locationNCT06904365
Recruiting
Phase 1
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Breast CancerPancreatic CancerGastric Cancer+6 more
GONGCHU Biotechnology Co., Ltd21 enrolled1 locationNCT06508307
Recruiting
Not Applicable
A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth
Breast CancerColon CancerHead and Neck Cancers
Centre for Research and Technology Hellas180 enrolled1 locationNCT07108517
Recruiting
Not Applicable
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
Breast CancerOvarian CancerEndometrial Cancer+6 more
University of California, San Francisco1,000 enrolled1 locationNCT05056077
Recruiting
Phase 2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Pancreatic CancerGastric CancerLung Cancer+15 more
Apollomics Inc.497 enrolled35 locationsNCT03175224